A carregar...
A prospective clinical trial of lenalidomide with topotecan in women with advanced epithelial ovarian carcinoma
BACKGROUND: Lenalidomide is an anti-angiogenic IMiD(®) immunomodulatory drug. The objective of this study was to determine the maximum tolerated dose (MTD), overall safety profile, and activity of oral lenalidomide in combination with topotecan in women with advanced epithelial ovarian or primary pe...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3236283/ https://ncbi.nlm.nih.gov/pubmed/21556801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10147-011-0243-1 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|